AUR104

AUR104 · Aurigene Discovery Technologies Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AUR104, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1) [Phase 1]